Buying Ecstasy Brussels

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buying Ecstasy Brussels

An investigation by Belgian broadcaster RTBF into online illegal drug sales has revealed that consumers no longer have to enter the 'dark web' to find sites that sell narcotics but that it can be done in much the same way as online shopping. The results of the investigation show that in fact there are many sites which are freely accessible on the 'classic' web providing a shopping experience much like regular retailers: online payments are possible via a QR code, some offer free delivery and in less than 24 hours if the order is placed before a certain time, and even the possibility of tracking the package. The RTBF journalists carrying out the investigation accessed a site which described itself as 'the specialist in the field of chemical research'. But at no time were they asked to provide any proof that they were there to do any research. RTBF journalists created a profile and ordered 10 grams of a drug offered on the website, for an amount which they could pay by scanning a QR code. After choosing to have the delivery sent to the RTBF headquarters the whole process was completed in less than three minutes. Two days later — rather than the hours as promised — the package arrived at RTBF: a simple bubble-protected envelope consisting of a small sealed bag. The investigators then had the substance inside tested by experts and indeed, it was 10 grams of the ordered narcotic. This kind of mail is usually intercepted by customs, especially if these are parcels sent from abroad and transiting through Belgium to return to another country. But customs tend to focus on heavy trafficking; the shipments of large quantities of drugs hidden by ingenious means. For shipments to individuals, it is more complicated, admits the head of customs, Kristian Vanderwaeren in the RTBF report. That's where you make a lot of money. The seizures we make are 10, or 5, ecstasy pills, but not two, three or five at a time. Since , Belgian legislation on narcotics has expanded. It bans a whole series of drugs, but also all derivatives of certain chemical structures. This makes it possible to encompass most synthetic drugs, even if their 'recipe' evolves slightly. This extension was made after Belgium experienced six deaths in six months due to synthetic drugs. Someone who orders illegal substances on a website faces two options in the eyes of the law: if the site is hosted in Belgium they will break the law as soon as they come into possession of these substances; if it's a foreign site, the person breaks the law from the moment the products enter Belgium. If the website is hosted in Belgium, it is itself illegal. Foreign-hosted websites will depend on the legislation of the country. But this does not change much for the Belgian buyer, who commits an infringement regardless of where the site is located. The RTBF investigation concluded when the reporters handed over the drugs at a police station and explained the context for their possession. The drugs were then recorded by the authorities and seized. Online drugs sales: Buying in Belgium made easy. Online drugs sales: Buying in Belgium made easy Saturday, 22 April By Nick Amies. Packets of cocaine. Gathering the evidence RTBF journalists created a profile and ordered 10 grams of a drug offered on the website, for an amount which they could pay by scanning a QR code. Related News 'Incredibly worried': Crack use in Brussels skyrockets Belgium in Brief: Carrots, sticks, and cocaine Two clandestine drug labs dismantled each month in Belgium If the website is hosted in Belgium, it is itself illegal.

XTC exhibition in Ghent: “Get people to think about alternative drug policy”

Buying Ecstasy Brussels

These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format. All countries. Topics A-Z. The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses. Best practice. We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon. Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it. All publications. More events. More news. We are your source of drug-related expertise in Europe. We prepare and share independent, scientifically validated knowledge, alerts and recommendations. About the EUDA. MDMA is a synthetic drug chemically related to the amphetamines, but with somewhat different effects. In Europe, MDMA use has generally been associated with episodic patterns of consumption in the context of nightlife and entertainment settings. On this page, you can find the latest analysis of the drug situation for MDMA in Europe, including prevalence of use, seizures, price and purity and more. European Drug Report — home. The drug situation in Europe up to Drug supply, production and precursors. Synthetic stimulants. Heroin and other opioids. New psychoactive substances. Other drugs. Injecting drug use in Europe. Drug-related infectious diseases. Drug-induced deaths. Opioid agonist treatment. Harm reduction. Reported use of the drug appeared to decline temporarily during periods of social distancing during the early phases of the COVID pandemic. The currently available data would, however, suggest an overall relatively stable level of consumption but with national variations in the recent trends observed and the caveat that overall supply side indicators are suggestive of a slight recent decline in availability. About half of the European cities reporting wastewater analysis found an increase in MDMA residues between and , although in most other cities some decline was noted. Overall, available indicators suggest that MDMA production continues within Europe, both for domestic consumption and for export to non-EU markets. The information available is strongly suggestive that most MDMA production continues to be largely concentrated in or around the Netherlands. There are some signs of a reduction in the volume being manufactured in the most recent data. An important caveat here is that this information mostly covers the first years of the pandemic and needs to be interpreted with caution. In addition, while overall the average MDMA content of tablets and purity of powders remained stable in , a recent decrease in the MDMA content of ecstasy tablets was noted in some important source countries, most notably the Netherlands. With a typical MDMA content of to milligrams, the overall strength of tablets available on the retail marketplace still remains high by historical standards. It is difficult to interpret the more recent data with any certainty, but a possible decline in production volumes and some reductions noted in MDMA tablet content may indicate that producers have experienced greater problems sourcing precursor chemicals or that some producers may have switched to producing other substances, either because of market demand or because they are more profitable. It may also reflect a perceived consumer demand for lower-strength products. The use of MDMA is rarely cited as a reason for entering drug treatment in Europe but acute poisonings and deaths are sometimes associated with the consumption of this substance. The use of MDMA therefore continues to represent an important issue for prevention and harm reduction messaging and interventions. The availability of higher strength products potentially increases the risk of adverse health outcomes associated with the consumption of this substance. Interestingly, a decline in MDMA-related presentations by a quarter was observed in sentinel hospital emergency departments with data for and This data set, however, is difficult to interpret in respect to overall trends, as it is not nationally representative, has limited coverage and may reflect either changes in consumption or reporting during the pandemic. While it is again difficult to generalise due to limitations in national and European coverage, the available information from drug checking services suggests that MDMA products are generally less subject to adulteration than other illicit drugs they screened in This does occur however, as illustrated by the inclusion of synthetic cathinones in MDMA tablets observed on some occasions. These sorts of mixtures may also increase the risk to consumers of experiencing unexpected adverse effects and potential harm. This data explorer enables you to view our data on the prevalence of MDMA use by recall period and age range. You can access data by country by clicking on the map or selecting a country from the dropdown menu. Prevalence data presented here are based on general population surveys submitted to the EMCDDA by national focal points. For the latest data and detailed methodological information please see the Statistical Bulletin Prevalence of drug use. Graphics showing the most recent data for a country are based on studies carried out between and Mean daily amounts of MDMA in milligrams per population. Sampling was carried out over a week in March and April Show source tables. Back to list of tables. Homepage Quick links Quick links. GO Results hosted on duckduckgo. Main navigation Data Open related submenu Data. Latest data Prevalence of drug use Drug-induced deaths Infectious diseases Problem drug use Treatment demand Seizures of drugs Price, purity and potency. Drug use and prison Drug law offences Health and social responses Drug checking Hospital emergencies data Syringe residues data Wastewater analysis Data catalogue. Selected topics Alternatives to coercive sanctions Cannabis Cannabis policy Cocaine Darknet markets Drug checking Drug consumption facilities Drug markets Drug-related deaths Drug-related infectious diseases. Recently published Findings from a scoping literature…. Penalties at a glance. Frequently asked questions FAQ : drug…. FAQ: therapeutic use of psychedelic…. Viral hepatitis elimination barometer…. EU Drug Market: New psychoactive…. EU Drug Market: Drivers and facilitators. Statistical Bulletin home. Quick links Search news Subscribe newsletter for recent news Subscribe to news releases. This make take up to a minute. Once the PDF is ready it will appear in this tab. Sorry, the download of the PDF failed. Table of contents Search within the book. Search within the book Operator Any match. Exact term match only. No overall trend emerges from the data on MDMA use. Of the 11 European countries that undertook surveys since and provided confidence intervals, 1 reported higher estimates than their previous comparable survey, 9 reported stable estimates and 1 reported a decrease. Seizures of MDMA precursors increased to 2. The Netherlands, however, reported a lower average MDMA content of ecstasy tablets mg per tablet. MDMA market in Europe. Table 2. Prevalence of drug use in Europe, trends Country Country code Geographical scope Substance Recall period Age Austria AT National Table 3. Masaryk Water Resesrch institute, p. Table 4. Table 5. Table 6. Table 7. Table 8. Table 9. Table Main subject. Target audience. Publication type. European Drug Report main page. On this page. Forensic Toxicology Labs. Prevalence data presented here are based on general populaton surveys submitted to the EMCDDA by national focal points.

Buying Ecstasy Brussels